An atlas of gene expression and gene co-regulation in the human retina by Pinelli, M et al.
Published online 27 May 2016 Nucleic Acids Research, 2016, Vol. 44, No. 12 5773–5784
doi: 10.1093/nar/gkw486
An atlas of gene expression and gene co-regulation in
the human retina
Michele Pinelli1,†, Annamaria Carissimo1,†, Luisa Cutillo1,2,†, Ching-Hung Lai1,†,
Margherita Mutarelli1,†, Maria Nicoletta Moretti1,†, Marwah Veer Singh1, Marianthi Karali1,
Diego Carrella1, Mariateresa Pizzo1, Francesco Russo3, Stefano Ferrari4, Diego Ponzin4,
Claudia Angelini3, Sandro Banfi1,5,* and Diego di Bernardo1,6,*
1Telethon Institute of Genetics and Medicine (TIGEM), Via Campi Flegrei 34, 80078 Pozzuoli, Italy, 2Dipartimento
Studi Aziendali e Quantitativi (DISAQ), Universita` degli studi di Napoli ‘Parthenope’, Via Generale Parisi, 80132
Napoli, Italy, 3Istituto per le Applicazioni del Calcolo, Consiglio Nazionale delle Ricerca, Via Pietro Castellino 111,
80131 Napoli, Italy, 4Fondazione Banca degli Occhi del Veneto, Via Paccagnella 11, 30174 Zelarino (Venice), Italy,
5Medical Genetics, Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, via
Luigi De Crecchio 7, 80138 Naples (NA), Italy and 6Dept. Of Chemical, Materials and Industrial Production
Engineering, University of Naples ‘Federico II’, Piazzale Tecchio 80, 80125 Naples, Italy
Received February 28, 2016; Revised May 19, 2016; Accepted May 20, 2016
ABSTRACT
The human retina is a specialized tissue involved in
light stimulus transduction. Despite its unique bi-
ology, an accurate reference transcriptome is still
missing. Here, we performed gene expression anal-
ysis (RNA-seq) of 50 retinal samples from non-
visually impaired post-mortem donors. We identified
novel transcripts with high confidence (Observed
Transcriptome (ObsT)) and quantified the expres-
sion level of known transcripts (Reference Transcrip-
tome (RefT)). The ObsT included 77 623 transcripts
(23 960 genes) covering 137 Mb (35 Mb new tran-
scribed genome). Most of the transcripts (92%) were
multi-exonic: 81% with known isoforms, 16% with
new isoforms and 3% belonging to new genes. The
RefT included 13 792 genes across 94 521 known
transcripts. Mitochondrial genes were among the
most highly expressed, accounting for about 10% of
the reads. Of all the protein-coding genes in Gen-
code, 65% are expressed in the retina. We exploited
inter-individual variability in gene expression to in-
fer a gene co-expression network and to identify
genes specifically expressed in photoreceptor cells.
We experimentally validated the photoreceptors lo-
calization of three genes in human retina that had
not been previously reported. RNA-seq data and
the gene co-expression network are available online
(http://retina.tigem.it).
INTRODUCTION
The retina is the specialized region of the central nervous
system that transduces light stimuli into neural signals. It is
formed by a concentric structure of three cell layers exter-
nally surrounded by the retinal pigment epithelium (RPE),
composed of tightly connected cells that form the blood-
retina barrier (1). The three retinal cell layers consist of
different cell types with specialized functions. The retina is
also the main target of a wide spectrum of disorders whose
features depend on the cell type that is primarily affected
(RetNet, https://sph.uth.edu/retnet/). Primary genetic de-
fects of photoreceptor cells cause inherited retinal diseases
(IRDs) that are characterized by broad clinical manifesta-
tions, ranging from isolated defects of the peripheral or cen-
tral retina to reduced acuity in low-light condition to com-
plete blindness (2). IRDs are the leading cause of blindness
among the working adult population (2) and causative mu-
tations have been found in over 100 genes (as for the Ret-
Net website in January 2016). Several families affected by
such conditions lack a conclusive genetic diagnosis (3–5)
thus suggesting the presence of additional, yet to be iden-
tified, causative genes.
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An accurate reference transcriptome (RefT) of the hu-
man retina may help in the discovery of new disease genes
(6,7). This is especially true for a neural tissue such as
the retina, where tissue-specific gene isoforms are more
frequently found than in non-neural tissues (8,9). RNA-
sequencing technology (RNA-seq) enables simultaneous as-
sessment of both transcript structure and expression level
within the same experiment (10). Only a few RNAseq stud-
ies have been performed in the human retina so far (11),
with a limited sample size (maximum 8 individuals). More-
over, expression data from these earlier studies is not always
publicly available. International efforts devoted to build-
ing RefTs in human tissues, such as the GTEx project
(12), have largely neglected retina. The only exception is
the Functional Annotation of the Mammalian Genome
(FANTOM) project (13) where transcription start sites in
a pooled sample of human retina were sequenced by means
of the Cap Analysis of Gene Expression (CAGE) technol-
ogy. The main reason for this lack of data is the difficulty in
collecting high-quality human retina specimens.
Here, we collected 50 high-quality post-mortem human
retinas from donors and performed high-coverage RNA-
sequencing analysis to yield a comprehensive RefT of the
human retina.Moreover, we exploited inter-individual vari-
ability in gene expression to infer a gene co-expression net-
work and to predict, via a guilty-by-association approach,
photoreceptor-specific expression of 253 genes. We experi-
mentally confirmed this specific expression for three genes.
MATERIALS AND METHODS
Human retina sample collection
Retina samples were collected at Fondazione Banca degli
Occhi del Veneto (FBOV) from 50 different donors for
cornea transplantation in compliance with the tenets of the
Declaration of Helsinki and after an informed consent al-
lowing the use of tissues for research purposes was signed
by the donor’s next of kin (for a description of donors Sup-
plementary Table S1). Each harvested tissue was accompa-
nied with the FBOV progressive number and with details
on the age and gender of donor, the cause of death and
the total post-mortem time (T). To limit the possible effects
of post-mortem time on RNA integrity and transcriptomic
profiles, retinal tissues were isolated only from eye bulbs
with a total post-mortem interval (T) ≤ 26 h. The average
post-mortem time of the samples was 20.5 h (ranging from
6 to 26 h). For the same reason, bulbs deriving from multi-
organ donors were excluded from the analysis. In order to
limit cross-contamination with adjacent tissues, we estab-
lished a protocol for the dissection of the retina from the
eye bulbs (14). The dissected retinal tissue was visually in-
spected to exclude any cross-contamination with the pig-
mented RPE/choroid and was immediately submerged in
RNA Stabilization Reagent (RNA later; QIAGEN).
RNA extraction, library preparation and sequencing
Total RNA was extracted from the 50 human retina sam-
ples using the miRNeasy Kit (QIAGEN) according to the
manufacturer’s instructions. RNA was quantified using a
NanoDropND-8000 spectrophotometer (NanoDropTech-
nologies) and the integrity was evaluated using an RNA
6000 Nano chip on a Bioanalyzer (Agilent Technologies).
The RNA of the 50 samples had an average RNA in-
tegrity number (RIN) of 8.7 (ranging from 7.2 to 9.7). Li-
braries were prepared according to manufacturer’s instruc-
tions (TruSeq RNA Sample Preparation kit) with an initial
amount of 4 g of total RNA. Quality control of library
templates was performed using aHigh Sensitivity DNAAs-
say kit (Agilent Technologies) on a Bioanalyzer (Agilent
Technologies). Qubit quantification platform was used to
normalize samples for the library preparation (Qubit 2.0
Fluorometer, Life Technologies). Libraries were sequenced
via a paired-end chemistry on an Illumina HiSeq1000 plat-
form with an average yield of ∼6 Mb.
Data analysis
The exploratory analysis, whose steps are shown in Figure
1, was carried out with the ‘tuxedo’ software suite (Trap-
nell et al., 2010) and led to the definition of the Observed
Transcriptome (ObsT). The conservative analysis (Figure 1)
was carried out by running the RNA-Seq by Expectation-
Maximization (RSEM) package (Li &Dewey, 2011) and led
to the definition of the RefT.
Reference transcriptome
Trimmed reads were aligned to Gencode transcripts by run-
ning RSEM with standard parameters (15). Aligned reads
(counts) were then used to estimate the gene expression
level of each Gencode transcript. Only genes with at least 1
count per million reads (1 CPM) in each of the 50 samples
were considered as expressed. By removing low count reads,
the histogram of count frequency versus logged length ap-
proached a Gaussian-like distribution (data not shown).
Gene expression values were then normalized within and
between samples. The within-sample normalization cor-
rects for gene-specific effects, e.g. related to gene length
or GC-content. Visual inspection of the data by scatter
plots revealed a nonlinear trend between count and gene
length but no trend with GC-content was apparent (Sup-
plementary Figure S1). We thus adopted a gene length
normalization method, namely full-quantile normalization
as discussed in Risso et al. using the withinLaneNormal-
ization function from the Bioconductor package EDASeq.
Between-sample normalization is needed to correct for dif-
ferences such as the sequencing depth. To this end, we em-
ployed the TMM (trimmed mean of M values) normaliza-
tion procedure (16,17) (Supplementary Figure S2). Finally,
we performed GSEA (18) with the ‘Gene Ontology’ gene-
set (MSIG ver 5) for functional interpretation of the most
expressed genes.
Observed transcriptome
Trimmed reads were aligned to the human genome, ver-
sion hg19 as downloaded fromUCSCgenome browserweb-
site (19), by using TopHat2 (20). TopHat2 allows RNA-
seq alignment guided by a RefT structure. To this end, we
used as reference a curated version of Gencode contain-
ing only high confidence (level 1 and 2), mitochondrial and
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Figure 1. The bioinformatics pipeline to analyse the 50 RNA-seq samples obtained from human donors.
non-redundant transcripts. According to this procedure, the
reads were preferentially aligned to the Gencode transcripts
and, when not possible, to the rest of the genome. In order
to compute the average genome-wide coverage (AC track)
of the retina transcriptome, the human genome (hg19) was
divided into bins of 100 nucleotides and then read coverage
was calculated in each bin by summing up the contribution
of all the 50 samples. Bins covered by less 100 reads were
considered as not expressed and assigned a ‘bin coverage’
value of 0. For bins with more than 100 reads, a ‘bin cov-
erage’ value was computed by first dividing the number of
reads falling in the bin in each sample by the total num-
ber of aligned reads in that sample and then by averaging
across the 50 samples. The ObsT was inferred by using Cuf-
flinks (20) guided by the Gencode RefT structure (the same
one used for the alignment). Cufflinks tries to resolve the
reads into the known transcripts whenever possible and to
infer novel transcripts otherwise. Transcripts were first in-
ferred at a single sample level. The 50 sample-level predic-
tions were then merged into a non-redundant consensus us-
ing cuffmerge and cuffcompare and all the transcripts that
had a 95% confidence interval including 0 inmore than 50%
of male or female samples were removed. This filtering cor-
responds to retain in the analysis only the genes that have
a probability of 0.5 of being present in one sample accord-
ing to the binomial distribution. We then applied cuffcom-
pare to annotate ObsT transcripts overlapping with Gen-
code transcripts. With very few exceptions, all of the ObsT
transcripts had some overlap with Gencode transcripts. To
check whether the hypothetical encoded proteins were also
similar between ObsT and Gencode transcripts, we com-
pared the predicted open reading frame (ORF) of ObsT
transcripts with the Gencode transcripts they overlapped
with. The ORF prediction was performed by selecting the
longest ORF with a starting and a stop codon within the
transcript. The bedtools ver 2.23, python ver 2.6.6, ver R
3.1.1 were used for the bioinformatic and statistical analy-
sis.
Gene network
The co-regulated genes were identified by computing the
Spearman correlation coefficient (SCC) between pair of
genes across the 50 samples. To this end, we quantified the
raw counts for each gene with RSEM and we then applied
the TMM between-sample normalization, but no within-
sample normalisation was applied, since the SCC is unaf-
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Table 1. Donor characteristics and average RNA integrity number (RIN)
Gender 18 Female and 32 Male
donors
Average Age 61.4 years (range 42÷72)
Cause of death Neoplastic disease: 38
Cardiovascular disease: 7
Injury/poisoning: 3
Digestive disease: 2
Average Sample Collection
Time (from time of death)
20.5 h
Average RIN value 8.5
fected by it. Only genes with at least 1 CPMper sample were
included in the analysis. For each genewe also excluded out-
liers using the conventional upper and lower limits of Q3
+ 1.5 × (Q3 − Q1) and Q1 − 1.5 × (Q3 − Q1), respec-
tively, keeping only samples within this region. A threshold
for the SCC of 0.85 was used to identify significantly co-
expressed genes. This threshold value corresponds to select
1.5% of all the possible gene-pairs that can be formed by
the 13.8K genes. In order to assess whether the gene net-
work captures known functional interactions among genes,
we used as a ‘gold-standard’ network, the collection of phys-
ical and functional interactions between genes reported in
the Search Tool for Recurring Instances of Neighbouring
Genes (STRING) database (21). In STRING, each inter-
action is associated with a score ranging from 0 to 999. A
score≥700 is recommended by the STRING authors to call
high confidence interactions. Hence, we selected interac-
tions with a score above 700 as the gold-standard network.
We then ranked gene-pairs in our gene co-expression net-
work according to their unsigned SCC in descending order
and computed the receiver operating characteristic (ROC)
curve by comparison to the STRING gold-standard net-
work. The resulting ROC is shown in Supplementary Fig-
ure S3 togetherwith the ‘random’ROCobtained by ranking
gene-pairs randomly.
Guilty-by-association
In order to identify genes that are expressed specifically
in photoreceptor cells, we applied a guilty-by-association
strategy to the co-expression network, as previously de-
scribed (22). Briefly, we first selected a list of known
photoreceptor-specific genes (PG, Supplementary Table S2)
from the literature, which was not meant to be exhaustive.
Next, for each gene in the network, we checked whether
the genes connected to it (i.e. its neighbours) were enriched
for PG. A gene was considered a candidate photoreceptor
gene (CPG) when it had among its neighbours a number
of PG larger than the expected one, according to (the False
Discovery Rate (FDR)-corrected) Fisher’s exact test. If the
number of gene neighbours was larger than 200, only the
top-200 most correlated genes were retained for the guilty-
by-association analysis. Similarly, in order to identify can-
didate genes for retinal diseases, we compiled a list of genes
known to cause retinal disease when mutated (RetNet dis-
ease gene (RDG), Supplementary Table S2) from the Ret-
Net website (accessed January 2015). The list of RDG was
used as input for the guilty-by-association analysis, thus ob-
taining a list of candidate disease genes (CDG).
RNA in situ hybridization
RNA in situ hybridization assays were performed on cryo-
sections. Antisense probes and sense (control) probes for
the tested transcripts were generated by polymerase chain
reaction (PCR) on human genomic DNA using primers
that were tailed with sequences recognized by the RNA
polymerases T3 and T7 (Supplementary Table S3). PCR
products were purified and used as templates for in vitro
cRNA transcription. To detect the probe, a hapten tag
(digoxigenin-labeled Uridine-5’-triphosphate (UTP)) was
incorporated into the RNA during the in vitro transcription
reaction (DIG RNA labelling kit; Roche). RNA ISH ex-
periments on human eye sections using cRNA probes were
performed as previously described (23). Hybridization was
performed at 65◦C.
Disease variants from Human Gene Mutation Database
(HGMD)
Disease variants involved in different diseases were ex-
tracted from HGMD (ver 2015) by applying broad fil-
ters. The ‘ocular’ disease mutation group was extracted by
searching for the following text string in the phenotype de-
scription field: ‘retina’, ‘eye’,’ vision’, ‘visual’, ‘blind’. Simi-
larly, (i) cardiac-, (ii) liver-, and (iii) immunological-disease
groups were extracted by using corresponding keywords: (i)
‘cardiac’, ‘heart’, (ii) ‘liver’, ‘hepatic’ and (iii) ‘immune’. A
further requirement was that variants had to be ‘causative’
and not just altering the disease risk.
RESULTS
We collected post-mortem tissue samples from 50 donors
not affected by retinal diseases (Table 1 and Supplemen-
tary Table S1). RNA sequencing was performed on all of
the samples, as detailed in the Materials and Methods sec-
tion, and it generated a total of 3550 M reads (average 72
M reads per sample, range 40–110M) corresponding to 290
260 Mb of sequence (average 5924 Mb per sample, range
2926–11 045 Mb). On average 79% of the reads were suc-
cessfully mapped to the human genome reference version
hg19 (Supplementary Figure S4 and Table S4).
We generated a UCSC genome browser track to report
the average coverage (AC) across the genomic sequence by
counting the number of mapped reads per 100 bp aver-
aged across the 50 samples. The final length of genome
that was covered by mapped reads was 238 Mb, corre-
sponding to 7.78% of the genome (http://retina.tigem.it -
‘Browser’ tab). Only a part of this region (∼178 Mb) was
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Figure 2. Overview of the Observed Transcriptome (ObsT). (A) Distribution of ObsT monoexonic transcripts and multiexonic transcripts that either
perfectly overlap a Gencode transcript (white), or share at-least one exon–exon junction with a Gencode transcript (blue), or share no exon–exon junctions
with Gencode transcript (black). (B) as in (A) but using genes rather than transcripts. (C) The frequency of transcripts’ alterations found in the ObsT
compared to the known reference sequence in Gencode. (D) The predicted ORF length of known-protein-coding transcripts (white), known non-protein-
coding transcripts (grey) and new transcripts found in the ObsT (blue); y-axis: the transcript density over the ORF-length; x-axis: ORF-length on a log-10
scale.
already reported to be expressed according to the Gen-
code RefT (Supplementary Figure S5). The median cover-
age was of 376 reads/100 bp (∼4 reads per bp) (Inter Quar-
tile Range (IQR)= 173÷ 1296 reads/100 bp). Interestingly,
the median coverage was much higher in the mitochondrial
genome with 2 215 966 reads/100 bp (∼22 160 reads per bp)
(IQR = 2 215 966 ÷ 4 920 964 reads/100 bp), which is sur-
prisingly high even considering the presence of thousands
of mitochondria per cell.
RNA-seq data were analysed following the pipeline
described in Figure 1. Specifically, we performed: (i) a
reference-based de novo transcriptome reconstruction in or-
der to identify putative novel transcripts expressed in the
human retina (ObsT) and (ii) a RefT analysis, in order to es-
timate the level of expression of known genes in the human
retina (RefT). Both analyses benefited from the availability
of 50 different samples, which were used to increase sensi-
tivity and specificity in the estimation of novel transcripts
and to increase the precision in the estimation of the ex-
pression level of individual transcripts. The bioinformatic
analysis pipelines to obtain the ObsT and the RefT differ
mainly in the read mapping strategy. The RefT pipeline em-
ploys RSEM, a reference-based strategy to estimate gene
expression levels starting from a set of reference transcript
sequences. The ObsT pipeline makes use of Tophat2 and
Cufflinks, which enable the discovery of novel transcripts at
the cost of a loss of precision in the estimation of the ex-
pression level of known transcripts.
Obst
TheObsTwas reconstructed by running TopHat 2 andCuf-
flinks on the sequencing data for each of the 50 samples
(Materials and Methods). In order to find a balance be-
tween a precise detection of rare transcripts and a small
number of False Positives, we performed an ensemble anal-
ysis of the 50 samples, as follows. We first run cufflinks to
infer the per-sample transcript structure from the TopHat2
aligned reads. An expression level and a 95% confidence in-
terval were assigned to each transcript. To merge the tran-
scriptome of the single samples into a unique RefT, we
removed transcripts whose expression confidence interval
included 0 and only retained those transcripts present in
the majority of both male and female individuals. We thus
identified 282 980 different exons that were joined into 77
623 isoforms for 23 960 genes (Figure 2A, B and Supple-
mentary Table S5). The ObsT covered 137 Mb (4.5%) of
the reference genome sequence, 35 Mb of which were not
annotated as transcribed regions in Gencode (Supplemen-
tary Figure S5). About 8% (6558) of the transcripts were
single-exon that generally belonged to single-isoform genes.
About half of them overlapped with a known transcript,
and a third of themwith perfect identity (Figure 2A). Of the
2366 novel single-exon transcripts, 328 (13%) overlap with
at least one lncRNA according to the database by Cabili
et al. (2011). Multi-exonic transcripts (71 065) were found
for 19 294 genes (Figure 2A, B and Supplementary Table
S5). Of these genes, 81% had at least one isoform whose
exon–exon junctions perfectly matched a known Gencode
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Figure 3. Overview of the Reference Transcriptome (RefT). (A) Cumulative distribution of mapped reads on gene regions prior to normalisation and
filtering. y-axis: cumulative distribution of reads; x-axis: the number of genes sorted by coverage in descending order (log10). Top-1, top-10, top-100,
top-1000 and top-10K expressed genes are marked. (B) Density distribution of expression for the genes in Gencode (white), for the photoreceptor-specific
genes (blue), and for RPE-specific genes (black). Gene density (y-axis) over the normalised expression level (x-axis) on a log-10 scale is shown. (C) The
average expression of genes in the human retina divided by chromosome.
transcript. The remaining isoforms were either putative new
alternative isoforms (16%) of known genes or entirely new
transcripts (3%).
Most of these new transcripts were likely non-coding as
the predicted length of the ORF was much shorter than
those of known protein-coding genes (Figure 2D). Sixty
of these new transcripts (belonging to 41 genes) mapped
to non-standard genome contigs (i.e. ‘unassembled’ or ‘al-
ternative’) and 53 of them overlapped a transcribed region
(according to the UCSC gene or the spliced-EST track)
(Supplementary Figure S6 reports two examples). Since the
ObsT was reconstructed with the guidance of a reference
genome that included only the standard chromosomes (1-
22, X, Y, mitochondrial), these 53 transcripts were pre-
dicted de novo by the bioinformatics analysis pipeline, thus
confirming the reliability of the ObsT. Hereafter, we will
not further consider genes and transcripts mapped to non-
standard chromosomes.
About 63% of the ObsT transcripts showed some dif-
ferences compared to the most similar Gencode transcript.
The most frequent alteration was the presence of at least
one different alternative splicing event (Figure 2C). The pre-
dicted protein sequence of half of the transcripts (i.e. the
longest ORF) was also altered. Interestingly, the most ex-
pressed isoforms were also the least variable (Supplemen-
tary Table S6, Figure S7). Finally, transcripts with a perfect
overlap with Gencode were more expressed than those with
a partial overlap and, in turn, those with a partial overlap
were more expressed than those with no overlap (new tran-
scripts) (Supplementary Figure S8).
Reft
The RefT was generated as shown in Figure 1. Briefly, for
each of the 50 samples, RSEMwas used to estimate the raw
counts of the transcripts annotated in Gencode. The raw
counts were normalized intra-samples and inter-samples
following standard procedures (Materials and Methods)
(16,17,24). Next, in order to obtain a single value of expres-
sion for each gene from the 50 samples, the median nor-
malised count was computed. The final RefT included 13
792 genes across 94 521 transcripts (Supplementary Table
S7A and Table S7B).
Principal component analysis (PCA) was used to check
for potential biases across the 50 samples. No obvious clus-
tering was apparent in the PCA plots (Supplementary Fig-
ure S9A) except when using sex chromosomes alone, where
two distinct male and female clusters appear as expected
(Supplementary Figure S9B). PCA analysis thus confirms
that sequencing was not flawed by potential confounding
factors either related to the experimental procedure (col-
lection of biological samples, post-mortem time, reagent
lots) or to donor characteristics (age and cause of death).
Similarly, contamination with RPE cells was excluded by
comparing the expression of RPE-specific genes (25) with
the overall gene expression and with that of photoreceptor-
specific genes (Figure 3B and Supplementary Figure S10).
The top-1000 most expressed genes in the human retina
are covered by 50% of the reads, whereas the top-10 000 by
almost 95% (Figure 3A). Genes localised to the mitochon-
drial chromosome (e.g. MT-ATP6, MT-CYB, MT-ND4,
MT-CO1) were among the most highly expressed genes, ac-
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Figure 4. Gene co-expression network and guilty-by-association analysis. (A) The genes co-expressed with RHO, one of the most expressed and function-
ally important retina genes, according to the gene co-expression network inferred from the 50 retina samples. (B), (C) and (D) show the genes co-expressed
with three Candidate Photoreceptor Genes (CPG): ANO2, LAPTM4B and PAQ4R. Grey lines represent gene-correlations higher than 0.85; ring colour
represents gene expression and filling colour reports the gene being Photoreceptor gene, CPG, Retinal disease gene and Candidate retinal disease gene. (E)
The legend for gene networks in Panel A, B, C and D.
counting for about 10% of the total reads (Supplementary
Figure S11). Out of all the genes annotated in Gencode,
23.8% are expressed in the retina, with a larger proportion
of genes annotated as ‘protein-coding’ (65%, Supplemen-
tary Table S7).
Overall, highly expressed genes were enriched by func-
tional classes related to visual perception (Supplemen-
tary Table S8 and Figure S12). Retinal disease-genes and
photoreceptor-specific genes were also highly expressed
(Supplementary Table S9 and Figure S13). Genes highly
variable among individuals (high Coefficient of Variation,
(CV)) were enriched for functional classes related to the
extracellular matrix and transmembrane ion permeability
(Supplementary Table S10A and Figure S14A). On the con-
trary, the least variable genes were enriched for classes re-
lated to the housekeeping functions (Supplementary Table
S10B and Figure S14B).
The ObsT and RefT share 13 367 genes in common, cor-
responding to about half (56%) of ObsT genes and almost
all (96%) of the RefT genes (Supplementary Figure S15A).
The expression levels of these shared genes were similar in
both the ObsT and the RefT (Supplementary Figure S15B,
SCC P-value < 10−16). Although the number of genes was
much higher in the ObsT than in the RefT, only a minor-
ity (19%) of the ObsT transcripts belonged to genes with-
out any isoform expressed in RefT (data not shown). In ad-
dition, ObsT-only genes were generally less expressed (SF,
Kruskal–Wallis test P-value < 10−16, Supplementary Fig-
ure S16) than those expressed also in the RefT and were
composed by a smaller number of transcripts (median 4 ver-
sus 1).
Gene Co-expression network and identification of novel can-
didate photoreceptor genes
We hypothesised that inter-individual variability in gene ex-
pression could be exploited to identify co-expressed genes in
the human retina. Gene co-expression implies functional or
physical interactions among genes (26,27).We used the SCC
to quantify gene–gene co-expression for all of the gene-pairs
in the RefT across the 50 samples. Since the RefT includes
13 792 genes, we computed the SCC for 95 102 736 gene-
pairs. In order to have a manageable number of gene-pairs
to work with, we selected a threshold for the SCC equal to
0.85, and selected only gene-pairs with an SCC higher than
0.85. The resulting gene network consists of 11 022 genes
and 1 401 990 edges connecting gene-pairs, which corre-
spond to about 1.5% of all the possible gene-pairs. About
one-half of the genes (53%) had more than 100 edges. In
order to assess the biological significance of the gene co-
expression network, we used as the gold standard a collec-
tion of functional and physical gene–gene interactions re-
ported in the STRING database (28). We sorted gene-pairs
in the network according to their absolute SCC value in de-
scending order and then checked whether each gene-pair
was supported by STRING or not. As shown in Supple-
mentary Figures S3A and B, we estimated the percentage
of correct connections to be significantly higher had these
been randomly guessed. These results confirm that the gene
network, which we inferred by exploiting inter-individual
variability in gene expression, contains some biologically
relevant information.
Gene networks can be used to assess the function
or tissue-specific expression of a gene via a guilty-by-
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association approach (22,29). This approach consists in as-
signing a function to a gene by checking whether there
is a shared function among its ‘gene neighbours’, i.e. the
set of genes connected to it in the network. We used the
guilty-by-association approach to identify genes specifi-
cally expressed in photoreceptors cells. To this end, we first
compiled a list of 60 genes known to be specifically ex-
pressed in photoreceptors (PG list in Supplementary Ta-
ble S2), we then searched for genes in the network whose
gene neighbours were significantly enriched in the PG list.
This guilty-by-association analysis resulted in 253 candi-
date photoreceptor-specific genes (CPG, Supplementary
Table S11) ranked according to the significance of their
enrichment. Thirty-four CPGs were included in the orig-
inal PG list (Odds ratio = 110, Fisher’s P-value < 10−16,
Supplementary Table S12), thus confirming the validity of
our approach. For example, Figure 4A shows that most
of the genes co-expressed with RHO are indeed PG like
RHO itself. Table 2 shows the top-15 most significant CPGs
(Supplementary Table S11 reports the whole list). Inter-
estingly, for most of these genes, we found literature and
database data supporting their expression in photoreceptor
cells (Supplementary Text).
We selected three genes from Table 2 for experimental
validation by means of RNA in situ hybridization on hu-
man retina tissues (ANO2, PAQR4, LAPTM4B). These
genes have not been previously reported to be expressed in
photoreceptor cells and limited knowledge of their roles in
retina pathophysiology is available in the literature: ANO2
(Figure 4B), whose mouse orthologue is known to be ex-
pressed in mouse retina, is involved in the regulation of cel-
lular membrane electric potential (30); PAQR4 (Figure 4C)
is a paralog of adiponectin receptor 1 and 2 (ADIPOR1
and ADIPOR2), both known to be expressed in photore-
ceptor cells. In additionADIPOR1 knock-out causes a form
of photoreceptor degeneration in mouse (31); LAPTM4B
(Figure 4D) encodes for a lysosome-associated transmem-
brane protein that has been never implicated in retina phys-
iology. RNA in situ hybridization experiments confirmed
that all of the 3 genes are significantly expressed in the pho-
toreceptor layer (Figure 5).
Gene networks have also been used in the literature to
prioritise disease-associated genes and for the diagnosis
of rare genetic disorders (32). We, therefore, decided to
apply the guilty-by-association approach to identify can-
didate retinal disease genes (CDG, Supplementary Table
S13). To this end, we first compiled a list of known reti-
nal disease genes (RDG) from the RetNet database (Sup-
plementary Table S2). We then searched for genes in the
network whose gene neighbours were significantly enriched
in the RDG list. As in the case of photoreceptor genes,
there was a significant enrichment of known RDG among
the CDG (Odds ratio = 15, Fisher’s P-value < 10−16, Sup-
plementary Table S12). Moreover, since we first compiled
the list of RDG (January 2015), 10 new genes have been
found to cause retinal diseases according to the RetNet
database (ATF6, DRAM2, HGSNAT, IFT172, LAMA1,
NEUROD1, POC1B, PRPS1, SPP2, KIZ). One of them
(IFT172) was among our CDG (enrichment P = 0.046).
We thus believe that the CDG list may be useful to re-
searchers and clinicians and hence, we made it available on-
line (http://retina.tigem.it).
DISCUSSION
We performed RNA-seq based transcriptome analysis of
50 retina samples from non-visually impaired post-mortem
donors. We estimated gene expression levels for all the
known genes and derived a gene co-expression network ex-
ploiting inter-individual variability in gene expression. We
identified a list of genes potentially expressed in photore-
ceptor cells and a list of candidate disease genes involved
in retinopathies. We also inferred novel retina-specific iso-
forms by de novo alignment of the RNA-seq reads to the
whole genome.
We applied two different bioinformatics pipelines to anal-
yse the RNA-seq data, one to obtain a high-confidence
RefT and the other to maximise the possibility of find-
ing novel transcripts (ObsT) (Figure 1). This dual strategy
enabled both a precise estimation of the expression of all
known genes and an overview of potentially novel tran-
scripts.
Interestingly, a large fraction of observed transcripts
originated from the mitochondrial chromosome (Figure 3C
and Supplementary Figure S11). This phenomenon has
been observed also in other tissues in the GTex study (12)
and it is in agreement with a previous study on retina tran-
scriptome (33). Mitochondrial gene overexpression in the
retina is probably related to the high energy demand of
this tissue (34). Indeed, mutations in mitochondrial genes
are known to cause retinal diseases (RetNet). Furthermore,
we found that genes with the ‘mitochondrial’ Gene On-
tology (GO) localization, either encoded by the mitochon-
drial or nuclear genome, were more expressed than other
genes (Mann–WhitneyU-testP< 10E-16, data not shown).
We excluded a potential contamination with mitochondrial
genome by observing that the read coverage in exonic re-
gions of mitochondrial genes was much higher than that in
non-exonic regions (Supplementary Figure S17).
RNA-seq data yield information both on isoform struc-
ture and expression in a single experiment, however, au-
tomatic transcript reconstruction is not always reliable. It
is known that de novo transcriptome assembly performs
well in the identification of regions that are actively tran-
scribed but tends to inaccurately define the 5′ and 3′ end-
points and exon–exon junctions (35). We found that most
of the inferred retina transcripts had some evidence of al-
teration compared to the reference sequence in Gencode
(59.1%, Figure 2C, Supplementary Table S6). This is prob-
ably an overestimation due to our decision to increase the
ability to discover new transcripts at the cost of an increase
in the False Positive rate. Nevertheless, our transcript re-
construction pipeline is able to keep the False Positive rate
low by using the 50 samples to filter out unreliable sample-
specific transcripts. Indeed, we were able to correctly recon-
struct transcripts in genomic regions that were not supplied
for the ‘guided’ alignment and transcript-inference (Supple-
mentary Figure S6).
The availability of 50 samples allowed us to correlate gene
expression among samples and to infer a gene co-regulation
network, which, despite its limitations, may be useful in elu-
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Table 2. Candidate photoreceptor genes (CPGs) resulting from the guilty-by-association analysis of the gene co-expression network
Gene FDR Expr. rank Comment Neighbour GO Enrichment
DPYSL3 6.25E-21 184 Neurite and axonal outgrowth Visual perception
Photoreceptor outer segment
Photoreceptor activity
C2orf71 4.05E-19 1041 Retinitis Pigmentosa 54 Fatty acid elongation, polyunsaturated f. . .
Calcineurin complex
Fatty acid elongase activity
CPLX4 8.37E-18 380 Expressed in mouse rod cells Chaperone-mediated protein complex assem. . .
Phagolysosome membrane
Lipid transporter activity
GSKIP 1.16E-17 4593 Potentially involved in photoreceptor cell survival Visual perception
Photoreceptor disc membrane
3’,5’-cyclic-nucleotide phosphodiesteras. . .
ANO2* 1.42E-16 320 Potentially involved in photoreceptor membrane potential and firing Detection of light stimulus
Photoreceptor outer segment
Potassium ion transmembrane transporter . . .
WLS 2.83E-16 1902 Mediate many developmental processes during embryogenesis Detection of light stimulus
Photoreceptor outer segment membrane
Voltage-gated potassium channel activity
GPR160 7.59E-16 2794 G-protein coupled receptor with unknown function Visual perception
Nonmotile primary cilium
Mannosyl-oligosaccharide 1,3-1,6-alpha-m. . .
PAIP2B 1.63E-15 3730 Influence membrane potential and light-dependent firing Visual perception
Cilium
Calmodulin binding
TMEM136 2.05E-15 2088 Transmembrane protein is expressed in mouse neuroretina Cellular potassium ion transport
Calcineurin complex
Voltage-gated potassium channel activity
AGPAT3 3.47E-15 243 Ubiquitous acetyltransferase involved in lipid metabolism Visual perception
Photoreceptor outer segment
Voltage-gated potassium channel activity
PAQR4* 3.89E-15 673 Structurally similar to ADIPOR1 and ADIPOR2 Visual perception
Photoreceptor disc membrane
3′ ,5′-cyclic-gmp phosphodiesterase activ. . .
LMOD1 6.39E-15 1440 Muscular antigen involved in Thyroid Ophthalmopathy Visual perception
Photoreceptor outer segment
Biotinidase activity
MEF2C 7.03E-15 5685 TF involved in multi-organs development including brain Visual perception
Cilium
Calmodulin binding
LAPTM4B* 1.49E-14 299 Lysosome-associated protein expressed in many tissues Visual perception
Cilium
Retinal binding
Only genes ranked in the top 15 positions according to their significance in the guilty-by-association analysis are shown (for the full list refer to Supplementary Table S13). FDR: false discovery rate. Expr.
Rank: rank of the gene in the retina with respect to its expression level (e.g. 1 being the most expressed). Comment: a manual-curated comment obtained by querying OMIM, PubMed andMGI. Neighbour
GO Enrichment: the most enriched GO term among the genes’ neighbours in the co-expression network.
cidating gene function. We confirmed that genes, which are
known to be expressed in specific cells or involved in specific
functions, tended to be co-expressed and exploited this in-
formation to find candidate photoreceptor genes. Similarly,
we inferred a list of candidate disease genes with a poten-
tial pathological role. Themost significant candidate disease
gene,GNB1, was already investigated as a potential disease-
gene on the basis of biomedical literature (36). It was proven
to cause a form of retinitis pigmentosa in a murine model
(37,38), but its definitive involvement in human disease is
still uncertain. The second most significant candidate dis-
ease gene was PAIP2B, which was expressed at an interme-
diate level (rank 3730) and was predicted also to be a candi-
date photoreceptor gene (P= 10−15). Interestingly, this gene
inhibits the translation of mature mRNAs by displacing
PABP from the 3′-end (39). If the involvement of this gene
in the retinal pathophysiology will be confirmed, it supports
the idea that the retina has a low tolerance for dysregula-
tion in RNA-maturation, in addition to its known sensi-
tivity to splicing machinery dysfunction (8). Interestingly
five of the candidate disease genes mapped to 3 genomic re-
gions linked to retinopathies for which the causative genes
are still unknown (RetNet). PHLPP2, KIFC3, CCDC113
localized within the Optic Atrophy 8 locus (OPA8, OMIM
616648) that was linked (LOD score 8.8) to a familiar form
of optic neuropathy (40); NT5E mapped within the Retini-
tis Pigmentosa 63 locus (RP63, OMIM 614494) linked to a
dominant form of retinitis pigmentosa (41) and TTC40 to
a dominant form of cone-rod dystrophy (CORD17) (42).
The retina transcriptome can be used for the prioriti-
zation of variants obtained from a sequencing study with
diagnostic/mutation-discovery purpose. Indeed, it is known
that selecting a representative transcriptome impacts the
prioritization efficacy (43) and this must be especially true
for tissues like retina, which makes a large usage of organ-
specific transcripts (8,9).
To date, other twoRNA-seq analyses of the human retina
transcriptome have been reported in the literature: Farkas
et al. (33) analysed 3 samples, while Li et al. (44) analysed 8
samples. Farkas et al. were mainly interested in the descrip-
tion of the neuroretina transcriptome, whereas Li et al. per-
formed differential expression analysis between neuroretina
and pigment epithelium and between macula and periph-
ery. Compared to these studies, ours benefited from a larger
sample size enabling a more precise estimation of gene ex-
pression and identification of alternative splicing events and
novel transcripts. Farkas et al. performed a de novo tran-
script reconstruction analysis on three samples and they
identified about 160K transcripts (compared to our 94K –
ObsT), with 29 887 novel exons, 28 271 exon skipping and
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Figure 5. In situ hybridisation in human retina for three candidate photoreceptor genes. Hybridisation of human retina sections with cRNA probes for (A
andD) PAQR4, (B and E) ANO2 and (C and F) LAPTM4B. For all three transcripts, a strong staining is detected in the inner segments of photoreceptors
(IS). PAQR4 is also expressed in the INL and strongly in the GCL. Figures D, E and F show a higher magnification of the photoreceptor inner and
outer segments. Ganglion Cell Layer; INL, Inner Nuclear Layer; IS, Photoreceptor Inner Segments; ONL, Outer Nuclear Layer; OS, Photoreceptor Outer
Segments; RPE.
21 757 alternative 5′ and 3′ exon events. Despite the differ-
ence in the total number of novel transcripts, both Farksas
et al. and us predict that about 50% of transcripts in the
retina have an altered structure compared to the reference
(Supplementary Table S6). Moreover, the results of novel
gene identification were generally consistent (27% of over-
lap), but with a relative increase of novel genes identified in
our study (206 novel genes compared to 114 in Farkas et
al.). We could not perform a detailed comparison with Li
et al., as their data are not publicly available. They identi-
fied about 18K genes as expressed in human retina, which
corresponds to about 80% of all the genes annotated in Ref-
Seq. Our analysis was more stringent and identified about
13K genes.
Recently, single-cell transcriptome analysis of human
retina has been performed to identify and categorise the dif-
ferent cell-types composing this complex tissue (45). One
limitation of single-cell transcriptomics with current tech-
nologies is their limited resolution power in terms of the
sample size and depth-of-coverage, resulting in a noisier sig-
nal for medium and low expressed transcripts (45). Hence,
the bulk transcriptome analysis reported in the present
manuscript led to the establishment of a reliable refer-
ence transcriptome that is very valuable to reconstruct co-
regulation relationships among genes.
CONCLUSIONS
We generated the most accurate and high-resolution atlas
of gene expression and gene co-regulation in human retina
to date, together with an online tool to quickly access and
explore the data (http://retina.tigem.it). We believe that this
atlas will represent a valuable resource for the research com-
munity at large and help in better elucidating pathophysio-
logical processes in the human retina.
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